A detailed history of Hyperion Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hyperion Partners, LLC holds 728 shares of AMGN stock, worth $226,240. This represents 0.15% of its overall portfolio holdings.

Number of Shares
728
Previous 1,467 50.37%
Holding current value
$226,240
Previous $423 Million 51.01%
% of portfolio
0.15%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$268.87 - $324.56 $198,694 - $239,849
-739 Reduced 50.37%
728 $207 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $11,151 - $13,844
51 Added 3.6%
1,467 $394 Million
Q2 2023

Jul 10, 2023

BUY
$214.27 - $253.37 $214 - $253
1 Added 0.07%
1,416 $314 Million
Q1 2023

Apr 11, 2023

BUY
$225.79 - $275.2 $225 - $275
1 Added 0.07%
1,415 $342 Million
Q4 2022

Apr 06, 2023

BUY
$229.03 - $291.01 $323,848 - $411,488
1,414 New
1,414 $371 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hyperion Partners, LLC Portfolio

Follow Hyperion Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyperion Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hyperion Partners, LLC with notifications on news.